James Mullen's practice includes strategic patent procurement, general counseling on infringement issues, and intellectual property due diligence studies. He also provides counseling on interference issues and reexamination practices and periodically participates in patent litigation.
Dr. Mullen counsels clients pursuing inventions in a variety of biotechnology-related areas, including cleantech, cancer therapeutics and diagnostics, infectious disease therapeutics, small molecule screening protocols, and those seeking protection for novel nucleic acid and amino acid sequence protection.
Prior to graduate school and law school, Dr. Mullen worked in various laboratories at Hybritech, Inc., a pioneer in the development of monoclonal antibodies, and at the Research Institute of Scripps Clinic.
In 2008, San Diego Daily Transcript named Dr. Mullen as a Top Attorney in Intellectual Property (Transactional).
While earning his J.D., Dr. Mullen was an Associate Production Editor for the Hastings College of the Law Communications and Entertainment Journal.